参考文献/References:
[1] Watkins K. Longer lives and unfinished agendas on child survival[J]. Lancet, 2016,388(10053):1450-1452.
[2] 中国心血管病报告编写组.《中国心血管病报告2016》概要[J]. 中国循环杂志, 2017,32(6):521-530.
[3] 范海荣, 孙福成. 炎症与动脉粥样硬化的研究进展[J]. 中华老年医学杂志, 2004(12):49-51.
[4] Carbone F, Nencioni A, Mach F, et al. Pathophysiological role of neutrophils in acute myocardial infarction[J]. Thromb Haemost, 2013,110(3):501-514.
[5] Ciz M, Denev P, Kratchanova M, et al. Flavonoids inhibit the respiratory burst of neutrophils in mammals[J]. Oxid Med Cell Longev, 2012,2012:1-6.
[6] Sivalingam Z, Larsen SB, Grove EL, et al. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease[J]. Clin Chem Lab Med, 2017,56(1):5-18.
[7] Stakos DA, Kambas K, Konstantinidis T, et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction[J]. Eur Heart J, 2015,36(22):1405-1414.
[8] Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria[J]. Science, 2004,303(5663):1532-1535.
[9] Bournazou I, Pound JD, Duffin R, et al. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin[J]. J Clin Invest, 2009,119(1):20-32.
[10] Zhang GY, Chen M, Yu ZM, et al. Relation between neutrophil-to-lymphocyte ratio and severity of coronary artery stenosis[J]. Genet Mol Res, 2014,13(4):9382-9389.
[11] Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography[J]. Atherosclerosis, 2012,225(2):456-460.
[12] Zuin M, Rigatelli G, Picariello C, et al. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience[J]. Cardiovasc Revasc Med, 2017,18(8):565-571.
[13] Kurtul A, Murat SN, Yarlioglues M, et al. Increased neutrophil-to-lymphocyte ratio predicts persistent coronary no-flow after wire insertion in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Clinics (Sao Paulo), 2015,70(1):34-40.
[14] Guo TM, Cheng B, Ke L, et al. Prognostic value of neutrophil to lymphocyte ratio for in-hospital mortality in elderly patients with acute myocardial infarction[J]. Curr Med Sci, 2018,38(2):354-359.
[15] Ipek G, Onuk T, Karatas MB, et al. Relationship between neutrophil-to-lymphocyte ratio and left ventricular free wall rupture in acute myocardial infarction[J]. Cardiology, 2015,132(2):105-110.
[16] Tahto E, Jadric R, Pojskic L, et al. Neutrophil-to-lymphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patients with acute coronary syndrome[J]. Med Arch, 2017,71(5):312-315.
[17] Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions[J]. J Exp Med, 2007,204(12):3037-3047.
[18] 何宝强. 急性心肌梗死患者平均血小板体积变化的意义[J].心血管病学进展, 2018,39(2):235-238.
[19] Chu H, Chen WL, Huang CC, et al. Diagnostic performance of mean platelet volume for patients with acute coronary syndrome visiting an emergency department with acute chest pain: the Chinese scenario[J]. Emerg Med J, 2011,28(7):569-574.
[20] Amraotkar AR, Song DD, Otero D, et al. Platelet count and mean platelet volume at the time of and after acute myocardial infarction[J]. Clin Appl Thromb Hemost, 2017,23(8):1052-1059.
[21] Seyyed-Mohammadzad MH, Eskandari R, Rezaei Y, et al. Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention[J]. Anatol J Cardiol, 2015,15(1):25-30.
[22] Fujii H, Li SH, Szmitko PE, et al. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells[J]. Arterioscler Thromb Vasc Biol, 2006,26(11):2476-2482.
[23] Fordjour PA, Wang Y, Shi Y, et al. Possible mechanisms of C-reactive protein mediated acute myocardial infarction[J]. Eur J Pharmacol, 2015,760:72-80.
[24] Qintar M, Sharma PP, Pokharel Y, et al. Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries[J]. Clin Cardiol, 2017,40(12):1205-1211.
[25] Milwidsky A, Ziv-Baran T, Letourneau-Shesaf S, et al. CRP velocity and short-term mortality in ST segment elevation myocardial infarction[J]. Biomarkers, 2017,22(3-4):383-386.
[26] La Franca E, Caruso M, Sansone A, et al. Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty[J]. Glob J Health Sci, 2013,5(4):48-54.
[27] Itakura H, Sobel BE, Boothroyd D, et al. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?[J]. Am Heart J, 2007,154(6):1059-1064.
[28] 任静,姚朱华.血浆D-二聚体检测在急性冠脉综合征中的临床价值[J].临床检验杂志, 2013(05):328-331.
[29] Reihani H, Sepehri SA, Keshmiri A. Diagnostic value of D-dimer in acute myocardial infarction among patients with suspected acute coronary syndrome[J]. Cardiol Res, 2018,9(1):17-21.
[30] Gorog DA. Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease[J]. J Am Coll Cardiol, 2010,55(24):2701-2709.
[31] Andresdottir MB, Sigfusson N, Sigvaldason H, et al. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study[J]. Am J Epidemiol, 2003,158(9):844-851.
[32] Yayan J. Erythrocyte sedimentation rate as a marker for coronary heart disease[J]. Vasc Health Risk Manag, 2012,8:219-223.
[33] Fatih OM, Sen N, Fatih KM, et al. Erythrocyte sedimentation rate in acute myocardial infarction as a predictor of poor prognosis and impaired reperfusion[J]. Med Glas (Zenica), 2012,9(2):189-197.
[34] Choi JJ, McCarthy MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018,18(1):27-34.
[35] Remskar M, Horvat M, Hojker S, et al. Procalcitonin in patients with acute myocardial infarction[J]. Wien Klin Wochenschr, 2002,114(5-6):205-210.
[36] Senturk T, Cordan J, Baran I, et al. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease[J]. Acta Cardiol, 2007,62(2):135-141.
[37] Kelly D, Khan SQ, Dhillon O, et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction[J]. Biomarkers, 2010,15(4):325-331.
[38] Picariello C, Lazzeri C, Attana P, et al. The impact of admission procalcitonin on prognosis in acute coronary syndromes: a pilot study[J]. Biomarkers, 2012,17(1):56-61.
[39] Bektas F, Soyuncu S, Gunduz I, et al. The value of procalcitonin, a novel inflammatory marker, in the diagnosis of myocardial infarction and evaluation of acute coronary syndrome patients[J]. J Emerg Med, 2011,41(5):524-530.
[40] Dai J, Xia B, Wu X. Elevated plasma procalcitonin level predicts poor prognosis of ST elevation myocardial infarction in Asian elderly[J]. Scand J Clin Lab Invest, 2018,78(1-2):49-54.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(6):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(6):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(6):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(6):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(6):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(6):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[9]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[10]朱建中 吴倩芸 刘峰.急性ST段抬高型心肌梗死“导管室误激活”的临床进展[J].心血管病学进展,2019,(5):739.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.019]
ZHU JianzhongWU QianyunLIU Feng.The Development of False-positive Activation of Cardiac Catheterization Laboratory with Acute ST Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):739.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.019]